Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Related Citations for PubMed (Select 24145091)

1.

Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo.

Hong SH, Lee HJ, Sohn EJ, Ko HS, Shim BS, Ahn KS, Kim SH.

Pharmacol Rep. 2013;65(4):970-9.

2.

Gallotannin suppresses calcium oxalate crystal binding and oxalate-induced oxidative stress in renal epithelial cells.

Lee HJ, Jeong SJ, Park MN, Linnes M, Han HJ, Kim JH, Lieske JC, Kim SH.

Biol Pharm Bull. 2012;35(4):539-44.

3.
4.
5.

Catechin prevents the calcium oxalate monohydrate induced renal calcium crystallization in NRK-52E cells and the ethylene glycol induced renal stone formation in rat.

Zhai W, Zheng J, Yao X, Peng B, Liu M, Huang J, Wang G, Xu Y.

BMC Complement Altern Med. 2013 Sep 17;13:228. doi: 10.1186/1472-6882-13-228.

6.

Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney.

Hirose Y, Yasui T, Taguchi K, Fujii Y, Niimi K, Hamamoto S, Okada A, Kubota Y, Kawai N, Itoh Y, Tozawa K, Sasaki S, Kohri K.

Urolithiasis. 2013 Aug;41(4):279-94. doi: 10.1007/s00240-013-0576-5. Epub 2013 Jun 11.

PMID:
23754513
7.

Temporal changes in the expression of mRNA of NADPH oxidase subunits in renal epithelial cells exposed to oxalate or calcium oxalate crystals.

Khan SR, Khan A, Byer KJ.

Nephrol Dial Transplant. 2011 Jun;26(6):1778-85. doi: 10.1093/ndt/gfq692. Epub 2010 Nov 15.

8.

Diphenyleneiodium (DPI) reduces oxalate ion- and calcium oxalate monohydrate and brushite crystal-induced upregulation of MCP-1 in NRK 52E cells.

Umekawa T, Byer K, Uemura H, Khan SR.

Nephrol Dial Transplant. 2005 May;20(5):870-8. Epub 2005 Mar 8.

9.

1,2,3,4,6-Penta-O-galloyl-beta-D-glucose reduces renal crystallization and oxidative stress in a hyperoxaluric rat model.

Lee HJ, Jeong SJ, Lee HJ, Lee EO, Bae H, Lieske JC, Kim SH.

Kidney Int. 2011 Mar;79(5):538-45. doi: 10.1038/ki.2010.458. Epub 2010 Nov 17.

10.

Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis.

Khan SR, Johnson JM, Peck AB, Cornelius JG, Glenton PA.

J Urol. 2002 Sep;168(3):1173-81.

PMID:
12187263
11.
12.

Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis.

Li CY, Deng YL, Sun BH.

Int Urol Nephrol. 2009 Dec;41(4):823-33. doi: 10.1007/s11255-009-9534-0. Epub 2009 Feb 25.

PMID:
19241135
13.

[Multifunctional character of osteopontin and strategy for clinical applications].

Tsuji H, Umekawa T, Uemura H.

Hinyokika Kiyo. 2011 Jan;57(1):49-54. Japanese.

14.

Molecular mechanism of oxalate-induced free radical production and glutathione redox imbalance in renal epithelial cells: effect of antioxidants.

Rashed T, Menon M, Thamilselvan S.

Am J Nephrol. 2004 Sep-Oct;24(5):557-68. Epub 2004 Nov 10.

PMID:
15539792
15.

Involvement of urinary proteins in the rat strain difference in sensitivity to ethylene glycol-induced renal toxicity.

Li Y, McLaren MC, McMartin KE.

Am J Physiol Renal Physiol. 2010 Sep;299(3):F605-15. doi: 10.1152/ajprenal.00419.2009. Epub 2010 Jun 9.

16.

Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.

Khan SR.

J Urol. 2013 Mar;189(3):803-11. doi: 10.1016/j.juro.2012.05.078. Epub 2012 Sep 25. Review.

PMID:
23022011
17.

Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1.

Park DW, Baek K, Kim JR, Lee JJ, Ryu SH, Chin BR, Baek SH.

Exp Mol Med. 2009 Mar 31;41(3):171-9. doi: 10.3858/emm.2009.41.3.020.

18.

Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.

Jiao B, Wang YS, Cheng YN, Gao JJ, Zhang QZ.

Biosci Trends. 2011 Aug;5(4):173-81. doi: 10.5582/bst.2011.v5.4.173.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk